Better Therapeutics, Inc. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported net loss was USD 8.77 million compared to USD 13.89 million a year ago. Basic loss per share from continuing operations was USD 0.37 compared to USD 0.71 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.009 USD | +11.11% | -18.18% | -95.38% |
03-21 | Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc | CI |
03-20 | Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-95.38% | 442K | |
+51.45% | 63.85B | |
-2.28% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.40% | 26.52B | |
-21.49% | 18.69B | |
+2.72% | 12.73B | |
+21.69% | 12.11B | |
+27.73% | 12.07B |
- Stock Market
- Equities
- BTTX Stock
- News Better Therapeutics, Inc.
- Better Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022